Exact Mass: 360.0681

Exact Mass Matches: 360.0681

Found 71 metabolites which its exact mass value is equals to given mass value 360.0681, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-Methylgallic acid 3-glucuronide

(2S,4S,6S)-6-(5-carboxy-3-hydroxy-2-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H16O11 (360.0693)

Ritipenem acetoxymethyl ester

[(2-{[(acetyloxy)methoxy]carbonyl}-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-en-3-yl)methoxy]carboximidate

C13H16N2O8S (360.0627)

Cyclocanaliculatin

C21H12O6 (360.0634)

ethyl loflazepate

ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate

C18H14ClFN2O3 (360.0677)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one

NCGC00380822-01!1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one

C19H17ClO5 (360.0764)

1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based on: CCMSLIB00000848321]

NCGC00380822-01!1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based on: CCMSLIB00000848321]

C19H17ClO5 (360.0764)

1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based: Match]

NCGC00380822-01!1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based: Match]

C19H17ClO5 (360.0764)

Methyl 18-bromo-9E,17E-octadecadien-5,7,15-triynoate

C19H21BrO2 (360.0725)

Methyl 18-bromo-9Z,17E-octadecadien-5,7,15-triynoate

C19H21BrO2 (360.0725)

Methyl 18-bromo-13E,17E-octadecatrien-5,7,15-triynoate

C19H21BrO2 (360.0725)

Methyl 18-bromo-9E,17E-octadecadien-5,7,15-triynoate

C19H21O2Br (360.0725)

Methyl 18-bromo-9Z,17E-octadecadien-5,7,15-triynoate

C19H21O2Br (360.0725)

Methyl 18-bromo-13E,17E-octadecatrien-5,7,15-triynoate

C19H21O2Br (360.0725)

2-chlorounguinol

C19H17O5Cl (360.0764)

PLATINUM-OCTANAL/OCTANOL COMPLEX

C8H18ClOPt (360.0694)

methyl 4-(4-chloro-[1]benzothiolo[2,3-d]pyrimidin-2-yl)cyclohexane-1-carboxylate

C18H17ClN2O2S (360.0699)

Pigment Yellow 6

C16H13ClN4O4 (360.0625)

4,4-BISMALEIMIDODIPHENYLETHER(44ODA/BMI)

C20H12N2O5 (360.0746)

Hexamethonium bromide

C12H30Br2N2 (360.0776)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D006584 - Hexamethonium Compounds D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) antagonist, with mixed competitive and noncompetitive activity. Hexamethonium Bromide has anti-hypertensive activity. Hexamethonium Bromide attenuates sympathetic activity and blood pressure in spontaneously hypertensive animal models[1][2][3][4].

1-(3,4-DIFLUOROBENZYL)-2-OXO-N-(THIOPHEN-2-YLMETHYL)-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE

C18H14F2N2O2S (360.0744)

a-D-erythro-Pentofuranosyl chloride, 2-deoxy-, dibenzoate (9CI)

C19H17ClO5 (360.0764)

Dimethyl 4,4-dinitro-2,2-biphenyldicarboxylate

C16H12N2O8 (360.0594)

4-Nitro-benzylphosphonobutanoyl-glycine

C13H17N2O8P (360.0722)

Ritipenem acetoxymethyl ester

C13H16N2O8S (360.0627)

2-[4-Ethoxy-2-[2-furanyl(oxo)methyl]imino-1,3-benzothiazol-3-yl]acetic acid methyl ester

C17H16N2O5S (360.078)

N-[(2-methyl-4-thiazolyl)methyl]-4-phenoxybenzenesulfonamide

C17H16N2O3S2 (360.0602)

Para-nitrophenyl phosphonobutanoyl D-alanine

C13H17N2O8P (360.0722)

N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine

C13H17N2O8P (360.0722)

N1-(5-Phospho-alpha-ribosyl)-5-methoxybenzimidazole

C13H17N2O8P (360.0722)

4-Methylgallic acid 3-glucuronide

C14H16O11 (360.0693)

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide

C17H16N2O5S (360.078)

(1S,3S,11R,11aR)-3-amino-1,7,11-trihydroxy-4-oxo-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinolin-8-yl hydrogen sulfate

C13H16N2O8S (360.0627)

5-[(2-Bromophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone

C16H17BrN4O (360.0586)

2-(4-Chlorophenyl)-3-(2-furanylmethyl)imidazo[4,5-b]quinoxaline

C20H13ClN4O (360.0778)

2-Amino-4-(4-chlorophenyl)-1-(4-methylphenyl)-6-oxopyridine-3,5-dicarbonitrile

C20H13ClN4O (360.0778)

2-Amino-1-(4-chlorophenyl)-4-(4-methylphenyl)-6-oxopyridine-3,5-dicarbonitrile

C20H13ClN4O (360.0778)

fumisoquin B zwitterion

C13H16N2O8S (360.0627)

A zwitterion obtained by transfer of a proton from the sulfate to the amino group of fumisoquin B; major species at pH 7.3.

N-[4-(4-nitrophenylphospho)butanoyl]alanine

C13H17N2O8P (360.0722)

6-(5-Carboxy-2-hydroxy-3-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H16O11 (360.0693)

2-chlorounguinol

C19H17ClO5 (360.0764)

fumisoquin B

C13H16N2O8S (360.0627)

A pyridoisoquinoline that is (11aR)-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinoline substituted by hydoxy groups at positions 1S,7 and 11R, by an amino group at position 3S, oxo group at position 4 and a sulfooxy group at position 8. It is produced by a biosynthetic gene cluster called fsq in the human pathogen Aspergillus fumigatus.

RO0711401

C18H11F3N2O3 (360.0722)

RO0711401 is a selective and orally active positive allosteric modulator of mGlu1 receptor with an EC50 of 56 nM[1][2].

5-chloro-6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-methyl-3,4-dihydro-2-benzopyran-1-one

C15H17ClO8 (360.0612)

4-[(2z)-but-2-en-2-yl]-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

C19H17ClO5 (360.0764)

methyl (9e,17e)-18-bromooctadeca-9,17-dien-5,7,15-triynoate

C19H21BrO2 (360.0725)

4-[(2e)-but-2-en-2-yl]-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

C19H17ClO5 (360.0764)

4-(but-2-en-2-yl)-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one

C19H17ClO5 (360.0764)

5-hydroxy-16-methyl-13,21-dioxapentacyclo[12.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]docosa-1(14),2(11),4,6,8,15,17,19-octaene-3,10,22-trione

C21H12O6 (360.0634)

8-hydroxy-6,15-dimethyl-12,20-dioxapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁴,¹⁹]henicosa-1(13),2(11),4,6,8,14(19),15,17-octaene-3,10,21-trione

C21H12O6 (360.0634)

(3r)-5-chloro-6-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-methyl-3,4-dihydro-2-benzopyran-1-one

C15H17ClO8 (360.0612)